Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

NNC0487-0111.

Research draft

NNC0487-0111 is a development code associated with amycretin.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Identity and evidence review notes

Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.

Identity or current programme status requires further checking.

Overview

NNC0487-0111 is a development code associated with amycretin.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Its proposed dual GLP-1 and amylin action should be assigned only after code and formulation are matched.

Human research

Relevant amycretin studies can be cross-linked, but the code is not an independent second evidence base.

Preclinical & other research

Laboratory findings require confirmation of the same active molecule.

Safety & unknowns

Oral and injectable preparations cannot share safety conclusions automatically.

Regulatory status

Retained as a catalogue entry; code, alias and formulation need identity review before publication.

Reported use & evidence

Research profile draft

The supplied NNC0487-0111 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds